TrialLeukemia2003

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

S Branford et al.PubMed ↗Publisher ↗

No numbers read from the abstract.